42C.SI - iX Biopharma Ltd.

SES - SES Delayed Price. Currency in SGD
Currency in SGD

Valuation measures

Market cap (intra-day) 5127.83M
Enterprise value 3120.52M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)168.87
Price/book (mrq)8.57
Enterprise value/revenue 3159.21
Enterprise value/EBITDA 6-11.19

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-21.20%
S&P500 52-week change 321.60%
52-week high 30.2850
52-week low 30.1900
50-day moving average 30.2110
200-day moving average 30.2150

Share statistics

Avg vol (3-month) 3294.54k
Avg vol (10-day) 368.78k
Shares outstanding 5648.89M
Float 298.32M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2019
Most-recent quarter (mrq)31 Dec 2019


Profit margin -252.71%
Operating margin (ttm)-1,545.84%

Management effectiveness

Return on assets (ttm)-32.12%
Return on equity (ttm)-78.23%

Income statement

Revenue (ttm)757k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)62.60%
Gross profit (ttm)-529k
EBITDA -10.77M
Net income avi to common (ttm)-12.09M
Diluted EPS (ttm)-0.0030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.78M
Total cash per share (mrq)0.02
Total debt (mrq)4.12M
Total debt/equity (mrq)27.26
Current ratio (mrq)4.87
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-10.04M
Levered free cash flow (ttm)-6.89M